Literature DB >> 23454038

The impact of cardiovascular risk-factor profiles on blood pressure control rates in adults from Canada and the United States.

Finlay A McAlister1, Cynthia Robitaille, Cathleen Gillespie, Keming Yuan, Deepa P Rao, Steven Grover, Sulan Dai, Helen Johansen, Michel Joffres, Fleetwood Loustalot, Norm Campbell.   

Abstract

BACKGROUND: It is unclear whether blood pressure control varies across the spectrum of atherosclerotic risk.
METHODS: We used data from nonpregnant adults who had fasted laboratory samples drawn for the 2007-2009 cycle of the Canadian Health Measures Survey (CHMS) or the 2005-2008 US National Health and Nutrition Examination Survey (NHANES).
RESULTS: The 1692 CHMS subjects and 3541 NHANES participants were demographically similar (aged a mean of 45 years), although NHANES participants exhibited higher obesity rates (33.8% vs. 22.2%, P < 0.001). Over 80% of CHMS and NHANES subjects with hypertension had at least 1 other cardiovascular risk factor. As the number of atherosclerotic risk factors increased, hypertension prevalence increased, but blood pressure control rates improved (from 48% among hypertensives with no other risk factors in CHMS to 77% among those with 3 or more risk factors, and from 35% to 53% in NHANES). However, the converse was not true: The distribution of Framingham risk scores for those subjects with "controlled hypertension" was nearly identical to the distribution among those adults with uncontrolled hypertension in both CHMS and NHANES and substantially higher than scores in normotensive subjects.
CONCLUSIONS: Although control of blood pressure was better in patients with multiple atherosclerotic risk factors, hypertensives with controlled blood pressures exhibited risk-factor profiles similar to those of participants with uncontrolled blood pressures. This suggests the need, in educational messaging and therapy decision making, for an increased focus on total atherosclerotic risk rather than just blood pressure control.
Copyright © 2013 Canadian Cardiovascular Society. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23454038      PMCID: PMC4494043          DOI: 10.1016/j.cjca.2012.12.004

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  33 in total

1.  Contemporary practice patterns in the management of newly diagnosed hypertension.

Authors:  F A McAlister; K K Teo; R Z Lewanczuk; G Wells; T J Montague
Journal:  CMAJ       Date:  1997-07-01       Impact factor: 8.262

2.  Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women.

Authors:  J Stamler; R Stamler; J D Neaton; D Wentworth; M L Daviglus; D Garside; A R Dyer; K Liu; P Greenland
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

Review 3.  The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.

Authors:  Stella S Daskalopoulou; Nadia A Khan; Robert R Quinn; Marcel Ruzicka; Donald W McKay; Daniel G Hackam; Simon W Rabkin; Doreen M Rabi; Richard E Gilbert; Raj S Padwal; Martin Dawes; Rhian M Touyz; Tavis S Campbell; Lyne Cloutier; Steven Grover; George Honos; Robert J Herman; Ernesto L Schiffrin; Peter Bolli; Thomas Wilson; Ross D Feldman; M Patrice Lindsay; Brenda R Hemmelgarn; Michael D Hill; Mark Gelfer; Kevin D Burns; Michel Vallée; G V Ramesh Prasad; Marcel Lebel; Donna McLean; J Malcolm O Arnold; Gordon W Moe; Jonathan G Howlett; Jean-Martin Boulanger; Pierre Larochelle; Lawrence A Leiter; Charlotte Jones; Richard I Ogilvie; Vincent Woo; Janusz Kaczorowski; Luc Trudeau; Simon L Bacon; Robert J Petrella; Alain Milot; James A Stone; Denis Drouin; Maxime Lamarre-Cliché; Marshall Godwin; Guy Tremblay; Pavel Hamet; George Fodor; S George Carruthers; George Pylypchuk; Ellen Burgess; Richard Lewanczuk; George K Dresser; Brian Penner; Robert A Hegele; Philip A McFarlane; Mukul Sharma; Norman R C Campbell; Debra Reid; Luc Poirier; Sheldon W Tobe
Journal:  Can J Cardiol       Date:  2012-05       Impact factor: 5.223

4.  Multiple cardiovascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research Group.

Authors:  S MacDonald; M R Joffres; S Stachenko; L Horlick; G Fodor
Journal:  CMAJ       Date:  1992-06-01       Impact factor: 8.262

Review 5.  The management of hypertension in Canada: a review of current guidelines, their shortcomings and implications for the future.

Authors:  F A McAlister; N R Campbell; K Zarnke; M Levine; I D Graham
Journal:  CMAJ       Date:  2001-02-20       Impact factor: 8.262

6.  Risk profiles and prognosis of treated and untreated hypertensive men and women in a population-based longitudinal study: the Reykjavik Study.

Authors:  L S Gudmundsson; M Johannsson; G Thorgeirsson; N Sigfusson; H Sigvaldason; J C M Witteman
Journal:  J Hum Hypertens       Date:  2004-09       Impact factor: 3.012

7.  Why cardiovascular mortality is higher in treated hypertensives versus subjects of the same age, in the general population.

Authors:  Athanase Benetos; Frédérique Thomas; Kathryn E Bean; Louis Guize
Journal:  J Hypertens       Date:  2003-09       Impact factor: 4.844

8.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Tony Dans; Alvaro Avezum; Fernando Lanas; Matthew McQueen; Andrzej Budaj; Prem Pais; John Varigos; Liu Lisheng
Journal:  Lancet       Date:  2004 Sep 11-17       Impact factor: 79.321

9.  High risk of cerebro-cardiovascular morbidity in well treated male hypertensives. A retrospective study of 40-59-year-old hypertensives in a Swedish primary care district.

Authors:  L Lindholm; G Ejlertsson; B Scherstén
Journal:  Acta Med Scand       Date:  1984

10.  Survival in treated hypertension: follow up study after two decades.

Authors:  O K Andersson; T Almgren; B Persson; O Samuelsson; T Hedner; L Wilhelmsen
Journal:  BMJ       Date:  1998-07-18
View more
  10 in total

Review 1.  The 2015 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: An update.

Authors:  Sherilyn K D Houle; Raj Padwal; Luc Poirier; Ross T Tsuyuki
Journal:  Can Pharm J (Ott)       Date:  2015-07

2.  Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE): 2014 update.

Authors:  Sheldon W Tobe; James A Stone; Kimberly M Walker; Todd Anderson; Onil Bhattacharyya; Alice Y Y Cheng; Jean Gregoire; Gord Gubitz; Mary L'Abbé; David C W Lau; Lawrence A Leiter; Paul Oh; Raj Padwal; Luc Poirier; Peter Selby; Mark Tremblay; Richard A Ward; Diane Hua; Peter P Liu
Journal:  CMAJ       Date:  2014-10-20       Impact factor: 8.262

3.  Take urgent action diagnosing, treating, and controlling hypertension in older women.

Authors:  Mark Gelfer; Alan Bell; Robert Petrella; Norm R C Campbell; Lyne Cloutier; Patrice Lindsay; Alexander A Leung; Dorothy Morris; Donna McLean; Ross T Tsuyuki; Shelita Dattani; Janusz Kaczorowski
Journal:  Can Fam Physician       Date:  2020-10       Impact factor: 3.275

4.  São Paulo call to action for the prevention and control of high blood pressure: 2020.

Authors:  Norm R C Campbell; Aletta E Schutte; Cherian V Varghese; Pedro Ordunez; Xin-Hua Zhang; Taskeen Khan; James E Sharman; Paul K Whelton; Gianfranco Parati; Michael A Weber; Marcelo Orías; Marc G Jaffe; Andrew E Moran; Frida Liane Plavnik; Venkata S Ram; Michael Brainin; Mayowa O Owolabi; Augstin J Ramirez; Eduardo Barbosa; Luiz Aparecido Bortolotto; Daniel T Lackland
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-11-25       Impact factor: 3.738

5.  Identification and evaluation of risk factors in patients with continuously uncontrolled hypertension.

Authors:  Kimberly J Low; Mitchell A Pelter; Robert L Deamer; Raoul J Burchette
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-02-09       Impact factor: 3.738

6.  Hypertension prevalence but not control varies across the spectrum of risk in patients with atrial fibrillation: A RE-LY atrial fibrillation registry sub-study.

Authors:  Finlay A McAlister; Rajibul Mian; Jonas Oldgren; Lars Wallentin; Michael Ezekowitz; Salim Yusuf; Stuart J Connolly; Jeff S Healey
Journal:  PLoS One       Date:  2020-01-15       Impact factor: 3.240

7.  [São Paulo call to action for the prevention and control of high blood pressure: 2020Chamado à ação de São Paulo para prevenção e controle da hipertensão arterial: 2020].

Authors:  Norm Rc Campbell; Aletta E Schutte; Cherian V Varghese; Pedro Ordunez; Xin-Hua Zhang; Taskeen Khan; James E Sharman; Paul K Whelton; Gianfranco Parati; Michael A Weber; Marcelo Orías; Marc G Jaffe; Andrew E Moran; Frida Liane Plavnik; Venkata S Ram; Michael Brainin; Mayowa O Owolabi; Agustin J Ramirez; Eduardo Barbosa; Luiz Aparecido Bortolotto; Daniel T Lackland
Journal:  Rev Panam Salud Publica       Date:  2021-02-26

8.  [São Paulo call to action for the prevention and control of high blood pressure: 2020Llamado a la acción de San Pablo para la prevención y el control de la hipertensión arterial, 2020].

Authors:  Norm Rc Campbell; Aletta E Schutte; Cherian V Varghese; Pedro Ordunez; Xin-Hua Zhang; Taskeen Khan; James E Sharman; Paul K Whelton; Gianfranco Parati; Michael A Weber; Marcelo Orías; Marc G Jaffe; Andrew E Moran; Frida Liane Plavnik; Venkata S Ram; Michael Brainin; Mayowa O Owolabi; Agustin J Ramirez; Eduardo Barbosa; Luiz Aparecido Bortolotto; Daniel T Lackland
Journal:  Rev Panam Salud Publica       Date:  2021-02-26

9.  Ups and downs of hypertension control in Canada: critical factors and lessons learned.

Authors:  Norm Rc Campbell; Raj Padwal; Ross T Tsuyuki; Alexander A Leung; Alan Bell; Janusz Kaczorowski; Sheldon W Tobe
Journal:  Rev Panam Salud Publica       Date:  2022-09-02

10.  Socioeconomic Impact on the Prevalence of Cardiovascular Risk Factors in Wallonia, Belgium: A Population-Based Study.

Authors:  Sylvie Streel; Anne-Françoise Donneau; Axelle Hoge; Sven Majerus; Philippe Kolh; Jean-Paul Chapelle; Adelin Albert; Michèle Guillaume
Journal:  Biomed Res Int       Date:  2015-08-25       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.